COVID-19 Evidence Alerts
from McMaster PLUS^TM

Current best evidence for clinical care (more info)

Last Updated: July 1, 2022 8:33 AM UTC

Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial.

Ochoa-Azze R, Chang-Monteagudo A, Climent-Ruiz Y, et al. Lancet Respir Med

Six-month follow-up of a booster dose of CoronaVac in two single-centre phase 2 clinical trials.

Xin Q, Wu Q, Chen X, et al. Nat Commun

Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.

Verleye A, Wijtvliet V, Abrams S, et al. Nephrol Dial Transplant

Loading articles...